Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.11 USD | -5.16% | -20.20% | -60.15% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.15% | 294M | |
+13.21% | 8.15B | |
-0.47% | 7.23B | |
+12.30% | 6.65B | |
-6.99% | 3.72B | |
-8.71% | 3.64B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-43.32% | 863M | |
-14.82% | 799M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024